Net Cash Provided by (Used in) Investing Activities of Intellipharmaceutics International Inc. from 30 Nov 2010 to 31 Aug 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Intellipharmaceutics International Inc. quarterly and annual Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 30 Nov 2010 to 31 Aug 2023.
  • Intellipharmaceutics International Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Aug 2023 was $0.
  • Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $500,000.
  • Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $0, a 100% decline from 2020.
  • Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $25,316.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

Intellipharmaceutics International Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $0 $0 01 Jun 2023 31 Aug 2023 6-K 16 Oct 2023 2023 Q3
Q2 2023 $0 -$500,000 -100% 01 Mar 2023 31 May 2023 6-K 26 Sep 2023 2023 Q2
Q3 2022 $0 $0 01 Jun 2022 31 Aug 2022 6-K 16 Oct 2023 2023 Q3
Q2 2022 $500,000 +$500,000 01 Mar 2022 31 May 2022 6-K 26 Sep 2023 2023 Q2
Q3 2021 $0 -$4,931 -100% 01 Jun 2021 31 Aug 2021 6-K 14 Oct 2022 2022 Q3
Q2 2021 $0 01 Mar 2021 31 May 2021 6-K 21 Jul 2022 2022 Q2
Q3 2020 $4,931 01 Jun 2020 31 Aug 2020 6-K 15 Oct 2021 2021 Q3

Intellipharmaceutics International Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $500,000 +$500,000 01 Dec 2021 30 Nov 2022 20-F/A 06 Feb 2024 2023 FY
2021 $0 -$25,316 -100% 01 Dec 2020 30 Nov 2021 20-F/A 06 Feb 2024 2023 FY
2020 $25,316 +$39,790 01 Dec 2019 30 Nov 2020 20-F/A 06 Feb 2024 2023 FY
2019 $14,474 01 Dec 2018 30 Nov 2019 20-F/A 09 May 2022 2021 FY
2013 $122,017 +$914,075 +88% 01 Dec 2012 30 Nov 2013 20-F 18 Feb 2014 2013 FY
2012 $1,036,092 -$773,950 -295% 01 Dec 2011 30 Nov 2012 20-F 18 Feb 2014 2013 FY
2011 $262,142 -$128,264 -96% 01 Dec 2010 30 Nov 2011 20-F 18 Feb 2014 2013 FY
2010 $133,878 01 Dec 2009 30 Nov 2010 20-F/A 01 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.